Ngā hua rapu - Nachbur, Ueli

NOD Signaling and Cell Death mā Heim, Valentin J., Stafford, Che A., Nachbur, Ueli

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

XIAP controls RIPK2 signaling by preventing its deposition in speck-like structures mā Ellwanger, Kornelia, Briese, Selina, Arnold, Christine, Kienes, Ioannis, Heim, Valentin, Nachbur, Ueli, Kufer, Thomas A

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Effect of Immunosuppressive Agents on Hepatocyte Apoptosis Post-Liver Transplantation mā Lim, Eu Jin, Chin, Ruth, Nachbur, Ueli, Silke, John, Jia, Zhiyuan, Angus, Peter W., Torresi, Joseph

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

A regulatory region on RIPK2 is required for XIAP binding and NOD signaling activity mā Heim, Valentin J, Dagley, Laura F, Stafford, Che A, Hansen, Fynn M, Clayer, Elise, Bankovacki, Aleksandra, Webb, Andrew I, Lucet, Isabelle S, Silke, John, Nachbur, Ueli

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

XIAP acts as a switch between type I and type II FAS-induced apoptosis signalling mā Jost, Philipp J., Grabow, Stephanie, Gray, Daniel, McKenzie, Mark D., Nachbur, Ueli, Huang, David C.S., Bouillet, Philippe, Thomas, Helen E., Borner, Christoph, Silke, John, Strasser, Andreas, Kaufmann, Thomas

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Eliminating hepatitis B by antagonizing cellular inhibitors of apoptosis mā Ebert, Gregor, Allison, Cody, Preston, Simon, Cooney, James, Toe, Jesse G., Stutz, Michael D., Ojaimi, Samar, Baschuk, Nikola, Nachbur, Ueli, Torresi, Joseph, Silke, John, Begley, C. Glenn, Pellegrini, Marc

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Oligomerization‐driven MLKL ubiquitylation antagonizes necroptosis mā Liu, Zikou, Dagley, Laura F, Shield‐Artin, Kristy, Young, Samuel N, Bankovacki, Aleksandra, Wang, Xiangyi, Tang, Michelle, Howitt, Jason, Stafford, Che A, Nachbur, Ueli, Fitzgibbon, Cheree, Garnish, Sarah E, Webb, Andrew I, Komander, David, Murphy, James M, Hildebrand, Joanne M, Silke, John

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Cellular inhibitor of apoptosis proteins prevent clearance of hepatitis B virus mā Ebert, Gregor, Preston, Simon, Allison, Cody, Cooney, James, Toe, Jesse G., Stutz, Michael D., Ojaimi, Samar, Scott, Hamish W., Baschuk, Nikola, Nachbur, Ueli, Torresi, Joseph, Chin, Ruth, Colledge, Danielle, Li, Xin, Warner, Nadia, Revill, Peter, Bowden, Scott, Silke, John, Begley, C. Glenn, Pellegrini, Marc

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

TRAF2 regulates TNF and NF-κB signalling to suppress apoptosis and skin inflammation independently of Sphingosine kinase 1 mā Etemadi, Nima, Chopin, Michael, Anderton, Holly, Tanzer, Maria C, Rickard, James A, Abeysekera, Waruni, Hall, Cathrine, Spall, Sukhdeep K, Wang, Bing, Xiong, Yuquan, Hla, Timothy, Pitson, Stuart M, Bonder, Claudine S, Wong, Wendy Wei-Lynn, Ernst, Matthias, Smyth, Gordon K, Vaux, David L, Nutt, Stephen L, Nachbur, Ueli, Silke, John

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Correction: TRAF2 regulates TNF and NF-κB signalling to suppress apoptosis and skin inflammation independently of Sphingosine kinase 1 mā Etemadi, Nima, Chopin, Michael, Anderton, Holly, Tanzer, Maria C, Rickard, James A, Abeysekera, Waruni, Hall, Cathrine, Spall, Sukhdeep K, Wang, Bing, Xiong, Yuquan, Hla, Timothy, Pitson, Stuart M, Bonder, Claudine S, Wong, Wendy Wei-Lynn, Ernst, Matthias, Smyth, Gordon K, Vaux, David L, Nutt, Stephen L, Nachbur, Ueli, Silke, John

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

TNFR1-dependent cell death drives inflammation in Sharpin-deficient mice mā Rickard, James A, Anderton, Holly, Etemadi, Nima, Nachbur, Ueli, Darding, Maurice, Peltzer, Nieves, Lalaoui, Najoua, Lawlor, Kate E, Vanyai, Hannah, Hall, Cathrine, Bankovacki, Aleks, Gangoda, Lahiru, Wong, Wendy Wei-Lynn, Corbin, Jason, Huang, Chunzi, Mocarski, Edward S, Murphy, James M, Alexander, Warren S, Voss, Anne K, Vaux, David L, Kaiser, William J, Walczak, Henning, Silke, John

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

A type III effector antagonises death receptor signalling during bacterial gut infection mā Pearson, Jaclyn S, Giogha, Cristina, Ong, Sze Ying, Kennedy, Catherine L, Kelly, Michelle, Robinson, Keith S, Wong, Tania, Mansell, Ashley, Riedmaier, Patrice, Oates, Clare VL, Zaid, Ali, Mühlen, Sabrina, Crepin, Valerie F, Marches, Olivier, Ang, Ching-Seng, Williamson, Nicholas A, O’Reilly, Lorraine A, Bankovacki, Aleksandra, Nachbur, Ueli, Infusini, Giuseppe, Webb, Andrew I, Silke, John, Strasser, Andreas, Frankel, Gad, Hartland, Elizabeth L

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

EspL is a bacterial cysteine protease effector that cleaves RHIM proteins to block necroptosis and inflammation mā Pearson, Jaclyn S., Giogha, Cristina, Mühlen, Sabrina, Nachbur, Ueli, Pham, Chi L. L., Zhang, Ying, Hildebrand, Joanne M., Oates, Clare V., Lung, Tania Wong Fok, Ingle, Danielle, Dagley, Laura F., Bankovacki, Aleksandra, Petrie, Emma J., Schroeder, Gunnar N., Crepin, Valerie F., Frankel, Gad, Masters, Seth L., Vince, James, Murphy, James M., Sunde, Margaret, Webb, Andrew I., Silke, John, Hartland, Elizabeth L.

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Insights Into Drug Repurposing, as Well as Specificity and Compound Properties of Piperidine-Based SARS-CoV-2 PLpro Inhibitors mā Calleja, Dale J., Kuchel, Nathan, Lu, Bernadine G. C., Birkinshaw, Richard W., Klemm, Theresa, Doerflinger, Marcel, Cooney, James P., Mackiewicz, Liana, Au, Amanda E., Yap, Yu Q., Blackmore, Timothy R, Katneni, Kasiram, Crighton, Elly, Newman, Janet, Jarman, Kate E., Call, Melissa J., Lechtenberg, Bernhard C., Czabotar, Peter E., Pellegrini, Marc, Charman, Susan A., Lowes, Kym N., Mitchell, Jeffrey P., Nachbur, Ueli, Lessene, Guillaume, Komander, David

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa